3 articles
Regen BioPharma reached a court-approved settlement to resolve a $398,740 claim by issuing shares of its stock, and it replaced its independent auditor after that firm’s attest business was acquired.
Waste Energy Corp. disclosed in its annual report that its recurring losses and working capital deficit raise substantial doubt about its ability to continue as a going concern, while the company works toward commercial operations at its Midland, Texas facility later this year.
Cue Biopharma secured approximately $50 million through a private stock sale to fund clinical development, while its own forward-looking statement disclosures acknowledge the company still faces a going concern determination and may not have enough capital to operate beyond the next twelve months.
© 2026 Record Alpha. All rights reserved.